Terms: = Skin cancer AND MAP3K1, ENSG00000095015, 4214, Q13233, MEKK1, MEKK, MAPKKK1
12 results:
1. Clinical Next-Generation Sequencing Panels Reveal Molecular Differences Between Merkel Cell Polyomavirus-Negative Merkel Cell Carcinomas and Neuroendocrine Carcinomas.
Hartsough E; Mino-Kenudson M; Lennerz JK; Dias-Santagata D; Hoang MP
Am J Clin Pathol; 2023 Apr; 159(4):395-406. PubMed ID: 36812363
[TBL] [Abstract] [Full Text] [Related]
2. Heritable genetic variants in key cancer genes link cancer risk with anthropometric traits.
Di Giovannantonio M; Harris BH; Zhang P; Kitchen-Smith I; Xiong L; Sahgal N; Stracquadanio G; Wallace M; Blagden S; Lord S; Harris D; Harris AHL; Buffa FM; Bond GL
J Med Genet; 2021 Jun; 58(6):392-399. PubMed ID: 32591342
[TBL] [Abstract] [Full Text] [Related]
3. Prolonged overall survival following metastasectomy in stage IV melanoma.
Elias ML; Behbahani S; Maddukuri S; John AM; Schwartz RA; Lambert WC
J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1719-1725. PubMed ID: 31070816
[TBL] [Abstract] [Full Text] [Related]
4. Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy.
Goh G; Walradt T; Markarov V; Blom A; Riaz N; Doumani R; Stafstrom K; Moshiri A; Yelistratova L; Levinsohn J; Chan TA; Nghiem P; Lifton RP; Choi J
Oncotarget; 2016 Jan; 7(3):3403-15. PubMed ID: 26655088
[TBL] [Abstract] [Full Text] [Related]
5. Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway.
Shain AH; Garrido M; Botton T; Talevich E; Yeh I; Sanborn JZ; Chung J; Wang NJ; Kakavand H; Mann GJ; Thompson JF; Wiesner T; Roy R; Olshen AB; Gagnon A; Gray JW; Huh N; Hur JS; Busam KJ; Scolyer RA; Cho RJ; Murali R; Bastian BC
Nat Genet; 2015 Oct; 47(10):1194-9. PubMed ID: 26343386
[TBL] [Abstract] [Full Text] [Related]
6. Cellular intrinsic factors involved in the resistance of squamous cell carcinoma to photodynamic therapy.
Gilaberte Y; Milla L; Salazar N; Vera-Alvarez J; Kourani O; Damian A; Rivarola V; Roca MJ; Espada J; González S; Juarranz A
J Invest Dermatol; 2014 Sep; 134(9):2428-2437. PubMed ID: 24717244
[TBL] [Abstract] [Full Text] [Related]
7. Low-copy piggyBac transposon mutagenesis in mice identifies genes driving melanoma.
Ni TK; Landrette SF; Bjornson RD; Bosenberg MW; Xu T
Proc Natl Acad Sci U S A; 2013 Sep; 110(38):E3640-9. PubMed ID: 24003131
[TBL] [Abstract] [Full Text] [Related]
8. Raf kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis in melanoma.
Das SK; Bhutia SK; Sokhi UK; Azab B; Su ZZ; Boukerche H; Anwar T; Moen EL; Chatterjee D; Pellecchia M; Sarkar D; Fisher PB
Cancer Res; 2012 Dec; 72(23):6217-26. PubMed ID: 23066033
[TBL] [Abstract] [Full Text] [Related]
9. Osteopontin stimulates melanoma growth and lung metastasis through NIK/mekk1-dependent MMP-9 activation pathways.
Rangaswami H; Kundu GC
Oncol Rep; 2007 Oct; 18(4):909-15. PubMed ID: 17786354
[TBL] [Abstract] [Full Text] [Related]
10. Curcumin suppresses AP1 transcription factor-dependent differentiation and activates apoptosis in human epidermal keratinocytes.
Balasubramanian S; Eckert RL
J Biol Chem; 2007 Mar; 282(9):6707-15. PubMed ID: 17148446
[TBL] [Abstract] [Full Text] [Related]
11. Apigenin inhibition of involucrin gene expression is associated with a specific reduction in phosphorylation of protein kinase Cdelta Tyr311.
Balasubramanian S; Zhu L; Eckert RL
J Biol Chem; 2006 Nov; 281(47):36162-72. PubMed ID: 16982614
[TBL] [Abstract] [Full Text] [Related]
12. cancer incidence rates among Japanese immigrants in the city of São Paulo, Brazil, 1969-78.
Tsugane S; de Souza JM; Costa ML; Mirra AP; Gotlieb SL; Laurenti R; Watanabe S
Cancer Causes Control; 1990 Sep; 1(2):189-93. PubMed ID: 2102290
[TBL] [Abstract] [Full Text] [Related]
